Accelerating Today’s Therapeutics
Leading global pharmaceutical organizations and emerging biopharma and gene and cell therapy companies trust ProtaGene’s analytical excellence, deep experience, and quality systems to accelerate and de-risk their therapeutic development programs.
Analytical Solutions from Research to Market
Our scientific expertise, experience across a wide range of therapeutics and regions, multi-continent foundation, and commitment to quality provide complete analytic solutions for protein biologics and gene and cell therapeutics throughout products’ development and regulatory life cycles—from discovery to market.
Expertise in characterization, advanced method development, late-stage and GMP commercial sample testing under GMP, and complete data packages for all stages of biotherapeutic development—from clone to commercialization.
Recombinant Proteins—Including Complex, Highly Glycosylated Proteins
Multi-subunit Complexes—Protein, Nucleotide, Ligand
Enzyme Replacement Therapies
ADCs and Protein Conjugates
Vaccines, Including Subunit/Recombinant
Gene and Cell Therapeutic Analytics
ProtaGene has led the industry in developing vector analytics advancing gene therapy safety, gene expression analysis, integration site analysis, genetic analytics, and related bioinformatics solutions.
Gene & Cell Therapeutic Platform Expertise
Complex, Envelope Vectors
Our Analytical Systems
Enabled by state-of-the-art technology, ProtaGene offers an extensive range of analytical capabilities to support your biotherapeutic or gene & cell therapy projects.
Enhanced Partnerships Offer Strategic Expertise
Perhaps you need support to overcome a specific challenge, or maybe you’re looking for a close partnership throughout your product’s entire life cycle. ProtaGene’s CMC experts are here to help.
New Peak Detection Performance Metrics from the MAM Consortium Interlaboratory Study
Analytical Artifacts in Characterization of Recombinant Monoclonal Antibody Therapeutics
Impact of Glycosylation on the Comparability of the Higher-Order Structures by Hydrogen-Deuterium Exchange Mass Spectrometry
Subscribe to Our Email List
Talk to Our Experts
Whether you are looking to learn more about our platforms or get a project started, contact our team today to discover how ProtaGene can support your development programs.Contact Us